Adaptive Designs in Clinical Drug Development

4-5 February 2009, Copthorne Tara Hotel, London, UK

As adaptive designs begin to move from theoretical discussion to practical implementation, SMi’s conference will provide a panel of top speakers whose knowledge and experience will give you the edge in your clinical research. Implementing Bayesian statistical models will impact on every part of your drug development, so it will be vital to understand the implications of this change – from the move towards a “learn and confirm” paradigm and the increasing necessity of using EDC and similar technologies, to the changing regulatory environment and the impact on supplies and randomisation in the trials themselves.
More info >>

BASi RECEIVES A EUROPEAN PATENT FOR CULEX

6th January 2009 - The Culex Automated In Vivo Sampling System is designed to collect pharmacokinetic and pharmacodynamic (PK/PD) data during the course of drug metabolism experiments. The Culex systems can collect blood, bile, urine, feces, dialysates and more – with greatly reduced trauma and stress from awake, freely moving animals.  In addition, an electronic report on both the dosing and the blood sampling experiments is generated automatically. 
More info >>